Free Trial

Colin Stuart Van Der Kuur Sells 15,000 Shares of Zentek Ltd. (CVE:ZEN) Stock

Zentek logo with Medical background

Zentek Ltd. (CVE:ZEN - Get Free Report) Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of the stock in a transaction on Thursday, May 8th. The shares were sold at an average price of C$2.20, for a total transaction of C$33,000.00.

Zentek Price Performance

ZEN traded down C$0.07 during midday trading on Monday, hitting C$2.16. The company had a trading volume of 56,283 shares, compared to its average volume of 44,925. The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06. The company has a market capitalization of C$221.90 million, a PE ratio of -20.38 and a beta of 0.77. Zentek Ltd. has a twelve month low of C$0.75 and a twelve month high of C$2.50. The firm's 50-day simple moving average is C$1.65 and its 200-day simple moving average is C$1.52.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines